A major hospital advocacy group recently warned that October 2024 agency guidance on Medicare drug price negotiations may allow drugmakers [...] …
Category: Federal
Federal lawmakers late last week approved a pared-down, must-pass federal spending bill, which cut back on health center funding and [...] …
The Senate Health, Education, Labor and Pensions (HELP) Committee—an influential panel with jurisdiction over the 340B program—will not only see [...] …
U.S. Rep. Earl “Buddy” Carter (R-Ga.), a pharmacist who has advocated for major changes to the 340B program which many [...] …
U.S. House Republican leaders this week unveiled and then quickly backed off of a year-end federal spending package following internal [...] …
The 119th Congress’ House Energy and Commerce (E&C) Committee—an influential panel with jurisdiction over the Medicaid and 340B programs—will feature [...] …
There are 435 members of the U.S. House and 100 U.S. Senators, and each one of them can influence the [...] …
A New Jersey congressman will again serve as the top Democrat on a key House committee, which has jurisdiction over [...] …
A San Diego-based drugmaker recently notified 340B covered entities of manufacturing and drug code changes for an antibiotic used to [...] …
Provider groups, including those with large numbers of 340B covered entity members, this week lauded U.S. Rep. Brett Guthrie’s (R-Ky.) [...] …